2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology …
V Delgado, N Ajmone Marsan, S de Waha… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
The changing epidemiology of infective endocarditis in the twenty-first century
J Ambrosioni, M Hernandez-Meneses, A Téllez… - Current infectious …, 2017 - Springer
Abstract Purpose of the Review Infective endocarditis (IE) is a relatively infrequent infectious
disease. It does, however, causes serious morbidity, and its mortality rate has remained …
disease. It does, however, causes serious morbidity, and its mortality rate has remained …
Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US
L Wang, ND Volkow, NA Berger, PB Davis… - Molecular …, 2023 - nature.com
The incidence of endocarditis in the US is increasing, driven in part by the rise in
intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine) …
intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine) …
Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs
L Rodger, SD Glockler-Lauf, E Shojaei… - JAMA Network …, 2018 - jamanetwork.com
Importance Persons who inject drugs (PWID) represent a distinct demographic of patients
with infective endocarditis. Many centers do not perform valvular surgery on these patients …
with infective endocarditis. Many centers do not perform valvular surgery on these patients …
Infective endocarditis by HACEK: a review
Infective endocarditis (IE) is a severe disease that is still associated with high mortality
despite recent advances in diagnosis and treatment. HACEK organisms (Haemophilus spp …
despite recent advances in diagnosis and treatment. HACEK organisms (Haemophilus spp …
Staphylococcus aureus bacteraemia and endocarditis – epidemiology and outcome: a review
H Asgeirsson, A Thalme, O Weiland - Infectious Diseases, 2018 - Taylor & Francis
Purpose: To review the epidemiology of Staphylococcus aureus bacteraemia (SAB) and
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …
endocarditis (SAE), and discuss the short-and long-term outcome. Materials and methods: A …
Current challenges in the management of infective endocarditis
G Cuervo, F Escrihuela-Vidal, C Gudiol… - Frontiers in …, 2021 - frontiersin.org
Infective endocarditis is a relatively rare, but deadly cause of sepsis, with an overall mortality
ranging from 20 to 25% in most series. Although the classic clinical classification into …
ranging from 20 to 25% in most series. Although the classic clinical classification into …
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections
Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections
and contributes to significant increase in morbidity and mortality especially when associated …
and contributes to significant increase in morbidity and mortality especially when associated …
A contemporary picture of enterococcal endocarditis
Background Enterococcal endocarditis (EE) is a growing entity in Western countries.
However, quality data from large studies is lacking. Objectives The purpose of this study was …
However, quality data from large studies is lacking. Objectives The purpose of this study was …
[PDF][PDF] 2023 ESC Guidelines for the management of endocarditis
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …